search
Back to results

Efficacy Study of "Imaginative Distention", a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS (DIMMISI)

Primary Purpose

Multiple Sclerosis

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
"Imaginative Distention" technique
Sponsored by
Niguarda Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • any gender, ethnicity
  • aged 18-65 years
  • ability to understand Italian to be able to conduct the study
  • adherence to the study by written informed consent
  • absence of serious internal medicine and psychiatric comorbidities

Exclusion Criteria:

  • under 18 and above 65 years
  • lack of understanding Italian to conduct of the studies
  • inability to provide informed consent
  • presence of severe internal medicine and psychiatric comorbidities

Specific criteria for inclusion:

Pw MS:

  • Diagnosis according to the criteria of Polman, 2011: relapsing remitting or progressive (primary and secondary)
  • Or in no specific drug therapy for the disease and symptomatic

Pw insomnia:

  • Diagnosis of psychophysiological insomnia according to DSM IV
  • Or in no specific drug therapy for the disease and symptomatic

Healthy professionals:

- Healthy personnel operating within the Niguarda Hospital

Sites / Locations

  • Azienda ospedaliera Ospedale Niguarda Ca' Granda

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Active Comparator

Active Comparator

Active Comparator

Arm Label

Multiple Sclerosis patients

Insomnia patients

Health professionists

Waiting list MS

Waiting list arm Insomnia

Waiting list arm Health professionists

Arm Description

Patients with MS

Patients with insomnia

Health professionists as healthy volunteers

pw MS filled the self administered questionnaire but they receive any training. They must wait study conclusion to be treated

pw INS Insomnia Subject filled the self administered questionnaire but they receive any training. They must wait study conclusion to be treated

Health professionist filled the self administered questionnaire but they receive any training. They must wait study conclusion to be treated.

Outcomes

Primary Outcome Measures

Fatigue
Evaluated with MFIS self administered questionnaire.Modified Fatigue Impact Scale (MFIS) is a self-assessment,values fatigue on daily life impact. Provides 21 items with 5-point Likert scale answer (from 0 = never to 4 = almost always).Total score ranges from 0 to 84 and includes three subscales:physical,cognitive and psychosocial fatigue (score ranges between 0-8)

Secondary Outcome Measures

Quality of life
Includes 54 items which generate 12 subscales with two summary scores, and two additional measures given by the single item.
Stress
It consists of 15 items and breaks down into five areas of evaluation which, when added, quantify the stress response: anxiety, depression, somatization, aggression, social support
Insomnia
Consists of 7 items answered on a 4-point Likert scales, refers to the Mental Disorders Manual DSM-IV criteria for insomnia, and assesses the Individual impact of the symptoms in the last 2 weeks
Physiological parameters and Neurological evaluation
The EDSS is the most widely used to assess neurological disability with a score between 0 and 10
Cognitive screening
Symbol Digit Modalities Test. Points 0-120. The California Verbal Learning Test - Second Edition. Points: 0-16 Visuospatial Memory Test - Revised. It takes 15 minutes. Points 0-36

Full Information

First Posted
October 7, 2014
Last Updated
March 31, 2017
Sponsor
Niguarda Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02290990
Brief Title
Efficacy Study of "Imaginative Distention", a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS
Acronym
DIMMISI
Official Title
A Randomized Controlled Trial on Integrated Imaginative Distention in MS Ans Insomnia: a Self Managed Tool to Cope With Fatigue, Stress and Insomnia
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
September 2014 (Actual)
Primary Completion Date
October 2015 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Niguarda Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Imaginative Distention (ID) is proposed as supportive and integrative intervention to cope with fatigue, (principal end point), to cope with insomnia, stress perception and to improve QoL of pw MS, insomnia pw and health care personnel. ID is safe and it can be easily learned and practised without of any particular instrument and also feasible in disabled pw. This technique allows persons to experience the body as a source of well-being and not just fatigue, pain and disease. ID can become a self managed tool of empowerment to cope with MS, to reduce its negative impact on daily life and job performances. Adherence to pharmacological therapies could be improved using ID. For pw MS ID could have specific and customizable rehabilitation implications to improve motor disability, as already seen in stroke patients. The principal end point of the trial is verify ID efficacy on fatigue and its specificity on pw MS at the end of the training. For this reason, ID efficacy will be tested in comparative terms too. Among all possible comparison populations, we selected: pw insomnia, which is stress related disease and health personnel, because at risk of stress. The control groups comparison permits to evaluate the specificity of ID on pw MS. The three groups are randomised to intervention or waiting list. The training is 8 weekly session long. Self administered questionnaire are filled by participants before and after the training, and 3-6 months later. The extent of change in outcome measure monitored in each exposed group vs. unexposed will allow to separate the non-disease specific effect of ID from the MS-specific effect. The difference in estimates will allow to determine the extent of the true effect of ID in pw MS. All outcome measure will be compared among all groups mentioned and over time. The study would identify also the most important outcome measures for MS patients questioning them in a focus group. This aspect is very important because could differs from which clinicians and researchers think about.
Detailed Description
Multiple sclerosis (MS) is a chronic neurological disorder with physical, emotional and cognitive symptoms. The diagnosis and the unpredictable and variable nature of the disease have profound social and psychological impact on persons with MS (pw MS). Fatigue, depression and disability are independent determinants of quality of life (QoL) and it is known that different kinds of stress may impact on disease activity. The "Imaginative Distention" (ID) is a mind-body technique that combines relaxation, imagination and motor imagery. ID derives from Progressive Muscle Relaxation Technique (PMRT) that was shown effective on fatigue in MS and in cancer patients, as well as cognitive behavioural psychotherapy, which includes relaxation. Mind-body modalities appear safe. ID can be easily learned and practised without any particular instrument and is also feasible in disabled pw MS. The aim of our study is to evaluate the effectiveness of ID as supportive and integrative intervention to cope with MS. We plan the first randomized controlled study (RCT) that will investigate the effectiveness of ID on fatigue (primary end point), disease specific QoL, insomnia, stress perception and physiological parameters. The primary outcome is the change in fatigue recorded post-intervention. Fatigue has a generically stress-related and a specifically disease-related component. To estimate the effect of ID on the specific MS-related component of fatigue, we will also monitor two additional groups of subjects, one with insomnia (with fatigue and poor QoL but with lesser impact on health condition) and one under generic stress (health professionals, with fatigue and normal to poor QoL and limited if any impact on health condition). Each study group - MS, insomnia, health professionals - will be randomised 1:1 to intervention or waiting list. The design is therefore parallel, randomised, controlled vs. no intervention, open, stratified by condition. Enrolment is voluntary. All participants will undergo a pre-evaluation visit which includes four self administered questionnaires (MFIS for fatigue, VRS Verbal Rating Scale for stress, ISI Insomnia Severity Index, MSQOL-54 Multiple Sclerosis Quality of Life), the EDSS Expanded Disability Status Scale and a brief cognitive screening for pw MS. After randomization, ID is practiced in groups, once a week, for two months. At the end, pw MS will be involved in focus groups to identify the agreement between investigator selected and patients-expected relevance of the outcomes used in the study, as well as other outcomes of relevance for the patients but not monitored in the study, to be possibly implemented in future trials. Follow up evaluations at two, five and eight months will include EDSS and the self-administered questionnaires and, at five months, the cognitive screening. If efficacy will be proved, ID could become a tool of empowerment to cope with MS, to reduce its negative impact on daily life and job performances and, possibly, to improve the adherence to pharmacological therapies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
144 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Multiple Sclerosis patients
Arm Type
Experimental
Arm Description
Patients with MS
Arm Title
Insomnia patients
Arm Type
Experimental
Arm Description
Patients with insomnia
Arm Title
Health professionists
Arm Type
Experimental
Arm Description
Health professionists as healthy volunteers
Arm Title
Waiting list MS
Arm Type
Active Comparator
Arm Description
pw MS filled the self administered questionnaire but they receive any training. They must wait study conclusion to be treated
Arm Title
Waiting list arm Insomnia
Arm Type
Active Comparator
Arm Description
pw INS Insomnia Subject filled the self administered questionnaire but they receive any training. They must wait study conclusion to be treated
Arm Title
Waiting list arm Health professionists
Arm Type
Active Comparator
Arm Description
Health professionist filled the self administered questionnaire but they receive any training. They must wait study conclusion to be treated.
Intervention Type
Behavioral
Intervention Name(s)
"Imaginative Distention" technique
Intervention Description
ID is an Imaginative relaxation technique which combines physical and mental relaxation. ID technique reaches physical relaxation through planned alternated movements taken from Jacobson PMRT which consist of specific muscle contractions and subsequent relaxations, with a precise temporal scanning. Psychological relaxation is achieved thanks to mental imagery (motor imagery, body scan, imagination).
Primary Outcome Measure Information:
Title
Fatigue
Description
Evaluated with MFIS self administered questionnaire.Modified Fatigue Impact Scale (MFIS) is a self-assessment,values fatigue on daily life impact. Provides 21 items with 5-point Likert scale answer (from 0 = never to 4 = almost always).Total score ranges from 0 to 84 and includes three subscales:physical,cognitive and psychosocial fatigue (score ranges between 0-8)
Time Frame
Change from baseline in MFIS score at two months + one week
Secondary Outcome Measure Information:
Title
Quality of life
Description
Includes 54 items which generate 12 subscales with two summary scores, and two additional measures given by the single item.
Time Frame
month 2;month 3;month 6
Title
Stress
Description
It consists of 15 items and breaks down into five areas of evaluation which, when added, quantify the stress response: anxiety, depression, somatization, aggression, social support
Time Frame
month 2;follow-up (month 3;month 6)
Title
Insomnia
Description
Consists of 7 items answered on a 4-point Likert scales, refers to the Mental Disorders Manual DSM-IV criteria for insomnia, and assesses the Individual impact of the symptoms in the last 2 weeks
Time Frame
month 2
Title
Physiological parameters and Neurological evaluation
Description
The EDSS is the most widely used to assess neurological disability with a score between 0 and 10
Time Frame
month 2,month 3;month 6
Title
Cognitive screening
Description
Symbol Digit Modalities Test. Points 0-120. The California Verbal Learning Test - Second Edition. Points: 0-16 Visuospatial Memory Test - Revised. It takes 15 minutes. Points 0-36
Time Frame
baseline,month 3

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: any gender, ethnicity aged 18-65 years ability to understand Italian to be able to conduct the study adherence to the study by written informed consent absence of serious internal medicine and psychiatric comorbidities Exclusion Criteria: under 18 and above 65 years lack of understanding Italian to conduct of the studies inability to provide informed consent presence of severe internal medicine and psychiatric comorbidities Specific criteria for inclusion: Pw MS: Diagnosis according to the criteria of Polman, 2011: relapsing remitting or progressive (primary and secondary) Or in no specific drug therapy for the disease and symptomatic Pw insomnia: Diagnosis of psychophysiological insomnia according to DSM IV Or in no specific drug therapy for the disease and symptomatic Healthy professionals: - Healthy personnel operating within the Niguarda Hospital
Facility Information:
Facility Name
Azienda ospedaliera Ospedale Niguarda Ca' Granda
City
Milano
ZIP/Postal Code
20162
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
28795383
Citation
Sgoifo A, Bignamini A, La Mantia L, Celani MG, Parietti P, Ceriani MA, Marazzi MR, Proserpio P, Nobili L, Protti A, Agostoni EC. Integrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis. Neurol Ther. 2017 Dec;6(2):213-223. doi: 10.1007/s40120-017-0081-9. Epub 2017 Aug 9.
Results Reference
derived

Learn more about this trial

Efficacy Study of "Imaginative Distention", a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS

We'll reach out to this number within 24 hrs